Clinical and immune modulatory effects of alternative weekly interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinoma and melanoma.

The clinical and immune modulatory effects of interleukin-2 (IL-2) and interferon (INF) alfa-2a were examined in a phase II study in patients with metastatic renal cell carcinoma (six patients) and melanoma (eight patients). Treatment consisted in IL-2 3 MU/m2 continuous infusion days 1-4 and INF al...

Descripción completa

Detalles Bibliográficos
Autores principales: Pichert, G., Jost, L. M., Fierz, W., Stahel, R. A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1991
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971775/
https://www.ncbi.nlm.nih.gov/pubmed/1997108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971775/
https://www.ncbi.nlm.nih.gov/pubmed/1997108

Ejemplares similares